In the previous study, Zhang et al. also showed that GAL1 induced hepatocellular carcinoma metastasis and resistance to sorafenib by upregulation of ανβ3-integrin and activated the PI3K/AKT pathway [36]. The gene discussed is GAL; the disease is hepatocellular carcinoma.